Navigation Links
PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022
Date:10/24/2013

nging competitive landscape for Alzheimer’s Disease
-Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
-Make more informed business decisions from insightful and in-depth analysis of drug performance
-Obtain sales forecast for drugs from 2012-2022 in China
Table of Contents

1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
3 Disease Overview 13
3.1 Etiology and Pathophysiology 14
3.1.1 Etiology 14
3.1.2 Pathophysiology 17
3.2 Symptoms 29
4 Disease Management 31
4.1 Diagnosis 31
4.1.1 Probable Alzheimer’s Disease Dementia 32
4.1.2 Possible AD Dementia 33
4.1.3 Probable AD Dementia with Evidence of AD Pathophysiological Process 33
4.1.4 Possible Alzheimer’s Dementia with Evidence of the Alzheimer’s Disease Pathophysiological Process 34
4.1.5 Preclinical AD 34
4.1.6 Mild Cognitive Impairment 35
4.2 Treatment Overview 37
4.3 China 40
4.3.1 Diagnosis 40
4.3.2 Clinical Practice 40
5 Competitive Assessment 42
5.1 Overview 42
5.2 Strategic Competitor Assessment 42
5.3 Product Profiles - Major Brands 45
5.3.1 Aricept (donepezil hydrochloride) 45
5.3.2 Exelon (rivastigmine, rivastigmine tartrate) 49
5.3.3 Razadyne (galantamine hydrobromide) 54
5.3.4 Namenda (memantine hydrochloride) 58
6 Opportunity and Unmet Need 62
6.1 Unmet Needs Overview 62
6.1.1 Public Awareness 64
6.1.2 Specialized Institutions at Local Levels 65
6.1.3 Screening and Diagnosis 65
6.1.4 Early Intervention 66
6.1.5 Improved Clinical Trial Design 67
6.1.6 Effective Therapy 68
6.1.7 Behavioral Treatments 69
6.2 Gap Analysis 69
6.2.1 Disease Prevention
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Alzheimer’s Disease - US Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
6. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
8. Changes in Epigenetic DNA Functions Reveal How Diabetes Predisposes Individuals to Alzheimer’s Disease
9. Diamond Fitness to Host Senior Dinner Dance to Raise Money for the Alzheimer’s Association
10. Eldercare Expert Judie Rappaport Releases New Report on the Rising Impact of Alzheimer’s Disease on the American Family
11. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... ERT, a ... cloud analytics and workflow solutions today announced the complete faculty of its ... 2015. The esteemed faculty of worldwide pharmaceutical and industry experts will lead ...
(Date:9/3/2015)... ... ... an unavoidable result of incision or injury to the skin. Unsightly as it may be, ... of a scar is dependent on many factors – the size and depth of the ... near invisibility on their own over a period of months,” says Dr. Jocelyn Lieb ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Mum n ... . The all-new product offers an extra-large size that gives maximum protection from sun ... with easy-to-use button attachment straps that deliver non-slip assurance by keeping the cover securely ...
(Date:9/3/2015)... Horeb, WI (PRWEB) , ... September 03, 2015 , ... ... us after becoming dissatisfied with the traditional health care model, where the primary care ... group of individuals who want to become educated about their health issues and empowered ...
(Date:9/3/2015)... ... September 03, 2015 , ... Local filmmakers and now co-hosts ... Michael Habernig from Path 11 Productions have had great success in launching their Path11 ... featured Hay House authors, Teal Swan who is the well known Spiritual Catalyst and ...
Breaking Medicine News(10 mins):Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3
... Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned ... that RLL has received approval from the U.S. ... Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) ... for the drug was submitted by Ranbaxy, from ...
... published in the Spring 2009 edition of Multiple ... Spinal Association ( www.UnitedSpinal.org ) and the North American ... importance of understanding the biological onset of Multiple Sclerosis ... greater understanding and treatment of MS in adults. The ...
... Two new Directors join the Board of the ... (Infectious Disease Research Institute) announced today that Dr. ... President (SVP) Scientific Affairs to assist the organization ... programs. Dr. Auditore-Hargreaves has a proven track record ...
... Hurricane Ike during a free public forum at Rice University ... Ed Emmett will discuss the leadership challenges they had to ... Guiding Houston through the Storm" will be held from 6 ... Rice campus, 6100 Main St. , In conjunction with ...
... Sick or injured African-American patients wait about ... before being transferred to an inpatient hospital bed ... national study published in the journal Academic ... underscore the urgency to find equitable, cost-effective solutions ...
... children and adolescents, with the active involvement of their ... the Seven Steps to Success described in the current ... published by Mary Ann Liebert, Inc. The article is ... A team of experts that includes physicians and psychologists ...
Cached Medicine News:Health News:Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets 2Health News:United Spinal Association Report Reveals the Importance of Studying Multiple Sclerosis in Children: Developing New Insights into MS in Adults 2Health News:IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs 2Health News:IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs 3Health News:Public forum at Rice with mayor and county judge marks 6-month Ike anniversary 2Health News:Racial disparities in emergency department length of stay point to added risks for minority patients 2Health News:Racial disparities in emergency department length of stay point to added risks for minority patients 3Health News:7 steps to successful child and adolescent weight loss 2
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 ... the addition of the "An Introduction to ... - November 2-3, 2015)" conference to their ... a comprehensive introduction to the regulations and requirements ... will be highly interactive, using real life examples ...
(Date:9/2/2015)... 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ... EU Pharmacovigilance Legislation (London, UK - November 16-17, 2015)" ... 15 new EU modules concerning Pharmacovigilance are a major ... in Europe . The intention of ... their requirements, examine how they overlap and fit together ...
(Date:9/2/2015)... Sept. 2, 2015  ArmaGen, Inc., a privately ... to treat severe neurological disorders, announced today that ... multi-center Phase 1/2a clinical trial of AGT-181 in ... AGT-181 is an investigational enzyme ... I. The most severe form of MPS I, ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4
... Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical ... neurological conditions, said today that it has received a ... Affordable Care Act to further the company,s ongoing clinical ... sports concussions. The Therapeutic Discovery grant was ...
... ATLANTA, Nov. 18, 2010 UCB, Inc., ... medications to treat immunology disorders, today announced the winners ... for outstanding individuals affected by this condition. UCB is ... deserving students seek personal growth through higher education. ...
Cached Medicine Technology:Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions 2Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions 32010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced 22010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced 32010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced 4
Transcranial vascular DWL doppler....
... 9100HS is a powerful automated system capable ... Choose from 6 user-programmable test protocols to ... exam. Any tests not included in the ... be handled using the Doppler, PVR and ...
The CD Horizon M8 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
... The VasoGuard from VIASYS Neurocare ... forward in physiologic vascular diagnosis. Exceptional ... and system reliability. , ,VasoGuard delivers ... The unique QuickConnect arm for cuff ...
Medicine Products: